Cancer Biology and Therapeutic Oncology

contact@imedpub.com Submit a Manuscript

Myeloma High Impact Factor Journals

Multiple myeloma (MM), otherwise called plasma cell myeloma and basic myeloma, is a malignant growth of plasma cells, a sort of white platelet that typically delivers antibodies. Frequently, no side effects are seen at first. As it advances, bone torment, dying, visit contaminations, and frailty may happen. Confusions may incorporate amyloidosis. The reason for different myeloma is obscure. Hazard factors incorporate weight, radiation presentation, family ancestry, and certain synthetics. Various myeloma may create from monoclonal gammopathy of unsure hugeness that advances to seething myeloma. The anomalous plasma cells produce irregular antibodies, which can mess kidney up and excessively thick blood. The plasma cells can likewise frame a mass in the bone marrow or delicate tissue. When one tumor is available, it is known as a plasmacytoma; more than one is called different myeloma. Different myeloma is analyzed dependent on blood or pee tests finding anomalous antibodies, bone marrow biopsy finding malignant plasma cells, and clinical imaging discovering bone lesions. Another normal finding is high blood calcium levels.

High Impact List of Articles
Conference Proceedings

Relevant Topics in Oncology & Cancer Science

Awards Nomination
Google Scholar citation report
Citations : 42

Cancer Biology and Therapeutic Oncology received 42 citations as per Google Scholar report

image
Abstracted/Indexed in
  • Publons

View More »

Open Access Journals